Lyophilized powderTesamorelin
Tesamorelin (GHRH 1-44 analog)
Tesamorelin is a synthetic analog of full-length human GHRH(1-44) with a trans-3-hexenoyl group attached at the N-terminus, conferring resistance to DPP-4 cleavage. It is distinguished from sermorelin and Modified GRF (1-29) by sequence length: those are truncated to the first 29 residues, whereas tesamorelin retains the complete 44-residue sequence. It has an established clinical literature, which is uncommon in this catalog.
Research applications
- GHRH receptor binding and activation studies
- Comparative studies against truncated GHRH analogs
- Visceral adipose tissue metabolism research
- IGF-1 axis response profiling
Storage
Store lyophilized at -20°C protected from light. Reconstituted at 2-8°C for up to 30 days.
Reconstitution
Reconstitute with bacteriostatic water down the vial wall. Swirl gently; do not shake.
Published literature
126 papers indexed on PubMed for Tesamorelin. Showing 6, reviews first.
- 01Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF et al. · J Am Acad Orthop Surg Glob Res Rev · 2026
- 02Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK et al. · Am J Sports Med · 2026
- 03Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports Med · 2026
- 04
- 05
- 06Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy
Spooner LM, Olin JL · Ann Pharmacother · 2012
Indexed from PubMed, 2026-07-19. We link to sources rather than reproducing them.
Related compounds
Ipamorelin
5–10mg · ≥99% pure
Highly selective pentapeptide ghrelin receptor agonist, notable for minimal cross-activation of other pituitary axes.
- CAS
- 170851-70-4
- MW
- 711.85
- Purity
- ≥99%
CJC-1295 (no DAC)
5–10mg · ≥99% pure
Modified GRF (1-29) analog with four amino acid substitutions conferring resistance to enzymatic degradation.
- CAS
- 863288-34-0
- MW
- 3367.9
- Purity
- ≥99%
IGF-1 LR3
1mg · ≥98% pure
83-amino-acid IGF-1 analog engineered for markedly reduced binding to IGF binding proteins.
- CAS
- 946870-92-4
- MW
- 9117.6
- Purity
- ≥98%